| Peer-Reviewed

An Evaluation of Common Neuropathies and the Rate of Physiotherapy Referral among Adults on Highly Active Antiretroviral Therapy (HAART) at Maina Soko Military Hospital, Lusaka, Zambia

Received: 1 March 2016    Accepted: 29 March 2016    Published: 25 April 2016
Views:       Downloads:
Abstract

Background: The advent of highly active antiretroviral therapy (HAART) has changed the prognosis of patients with Human Immunodeficiency Virus (HIV) from invariable death to a manageable chronic condition, with a near-normal life expectancy. However, sensory peripheral neuropathy remains the common complication despite the effective combination of HAART. Little has been reported on the extent of the problem of common neuropathies in adults on HAART in Zambia. Purpose: To determine the prevalence of common neuropathies in adults on HAART and rate of physiotherapy referral among the patients that were seen at the Maina Soko Military Hospital (MSMH). Methods and Results: Data was collected retrospectively from clinical files of patients that were treated on HAART between the years 2011-2013 using a checklist. The statistical package for social sciences (SPSS) version 20 was used for descriptive analysis. A total of 214 clinical files of adults on HAART were identified during the period under review and only 24 cases had some form neuropathies giving a period prevalence of 11.2%. The majority 46% (n=11) age range being 31 to 45 years with more 58% (n=14) females than males 42% (n=10). Almost half 54% (n=13) of the patients were on tenofovir, lamivudine and efavirenz. The most common type of neuropathy 59% (n=14) was polyneuropathy with autonomic neuropathies as co-morbidities and most of these patients 75% (n=18) had not been referred to physiotherapy. Conclusions: Neuropathies are becoming a common problem in patients on HAART given the rising prevalence. Rate of physiotherapy referral among the cases is very low. It is highly recommended that another study on prevalence of neuropathies in adults on HAART be done over a longer period of time to include other hospitals in Zambia. Physiotherapists in Zambia are also challenged to provide evidence on the impact of the interventions given to patients with neuropathies on HAART.

Published in International Journal of Neurologic Physical Therapy (Volume 2, Issue 2)
DOI 10.11648/j.ijnpt.20160202.11
Page(s) 12-18
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

HAART, HIV/AIDS, Prevalence, Neuropathies, Physiotherapy, Zambia

References
[1] Tan JY, Earnshaw VA, Pratto F, Rosenthal L, Kalichman S. Social-structural indices and between-nation differences in HIV prevalence. Int J STD AIDS. 2015; doi: 10.1177/0956462414529264.
[2] Doherty T et al. 'Effect of home based HIV counselling and testing intervention in rural South Africa: cluster randomised trial' BMJ. 2013; 346: 348.
[3] UNAIDS (2014) 'The Gap Report 2014.'
[4] Kamali A, Price MA, Lakhi S, Karita E, Inambao M, Sanders EJ, et al. Creating an African HIV Clinical Research and Prevention Trials Network: HIV Prevalence, Incidence and Transmission. PLoS ONE. 2015; 10(1): e0116100.
[5] Skarbinski J, Rosenberg E, Paz-Bailey G, et al. Human immunodeficiency virus transmission at each step of the care continuum in the United States. JAMA Intern Med. 2015; 175: 588–96.
[6] Nyawira TG, Kiarie JN, Mutai KK, Gatumia BW, Gatongi PM, Lakati A. Socio-economic determinants of disease progression among HIV infected adults in Kenya BMC Public Health. 2015; 15: 733.
[7] Kesetebirhan DY, Hattingh S. Prevalence and Predictors of Immunological Failure among HIV Patients on HAART in Southern Ethiopia: PLoS One. 2015; 10(5): e0125826.
[8] Carvour ML, Harms JP, Lynch CF, Mayer RR, Meier JL, Liu D, et al. Differential Survival for Men and Women with HIV/AIDS-Related Neurologic Diagnoses. PLoS ONE. 2015;10 (6): e0123119.
[9] Nixon S, Forman L, Hanass-Hancock J et al. Rehabilitation:A crucial component in the future of HIV care and support. South Afr J HIV Med 2011a: 12, 12, 14, 16, 17.
[10] Price RW, Spudich SS, Peterson J, Joseph S, Fuchs D, Zetterberg H, et al. Evolving character of chronic central nervous system HIV infection. Seminars in Neurology. 2014; 34: 7–13.
[11] Bilgrami M, O'Keefe P. Neurologic diseases in HIV-infected patients. Handbook of Clinical Neurology. 2014; 121: 1321–1344.
[12] Wada NI, Jacobson LP, Margolick JB, Breen EC, Macatangay B, Penugonda S, Martínez-maza O, Bream JH. The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation. AIDS. 2015; 29(4): 463–471.
[13] Nixon SA, Hanass-Hancock J, Whiteside A, Barnett T. The increasing chronicity of HIV in sub-Saharan Africa: Rethinking“HIV as a long-wave event” in the era of widespread access to ART. Glob Health 2011b: 7: 41.
[14] Arenas-Pinto, A; Thompson, J; Musoro, G; Musana, H; Lugemwa, A; Kambugu, A; Mweemba, A; (2015) Peripheral neuropathy in HIV patients in sub-Saharan Africa failing first-line therapy and the response to second-line ART in the EARNEST trial. Journal of Neurovirology 10.1007/s13365-015-0374-7.
[15] Philomène, K.-N., Thierry, A., Landry, O., James, I., Yvonne, A.-Z., Martine, M.M. and Gertrude, M.M. Distal Sensory Polyneuropathy among HIV Patients in Libreville in Gabon. Neuroscience & Medicine. 2015; 6, 84-89.
[16] Ayub M, Ayub S, Masood F, Afzal A, Shafique M, et al. Evaluation of Predisposing and Comorbodities Associated with Diabetes Mellitus in Pakistan. J Diabetes Metab. 2015; 6: 581. doi: 10.4172/2155-6156.
[17] Underwood J, Robertson KR, Winston A: Could antiretroviral neurotoxicity play a role in the pathogenesis of cognitive impairment in treated HIV disease? AIDS. 2015, Vol 29, No 3.
[18] Grace JM, Stuart J. Semple, Susan Combrink: Exercise therapy for human immunodeficiency virus/AIDS patients: Guidelines for clinical exercise therapists: Journal of Exercise Science and Fitness. 2015; (13): 49-56.
[19] Bopp CM, Phillips KD, Fulk LJ, et al. Physical activity and immunity in HIV infected individuals. AIDS Care. 2004; 16: 387e393.
[20] Millogo A, Lankoande D, Yameogo I, Yameogo AA, Sawadogo AB. Polyneuropathies in patients treated with HAART in Bobo-Dioulasso hospital, Burkina Faso [in French]. Bull Soc Pathol Exot 2008; 101: 11–3.
[21] Subsai K, Kanoksri S, Siwaporn C, Helen L. Neu-rological complications in AIDS patients: the 1-year retrospective study in Chiang Mai Univer-sity, Thailand. Eur J Neurol 2004; 11: 755-9.
[22] Forna F, Liechty CA, Solberg P, Asiimwe F, Were W, Mermin J, Behumbiize P, Tong T, Brooks JT, Weidle PJ. Clinical toxicity of highly active antiretroviral therapy in a home-based AIDS care program in rural Uganda. J Acquir Immune Defic Syndr. 2007; 44: 456–462.
[23] Sapna A. Mehta, Aabid Ahmed, Maura Laverty, Robert S. Holzman, Fred Valentine, and Sumathi Sivapalasingam. Sex Differences in the Incidence of Peripheral Neuropathy among Kenyans Initiating Antiretroviral Therapy. Clinical Infectious Diseases. 2011; 53(5): 490–496.
[24] Currier JS, Spino C, Grimes J, et al. Differences between women and men in adverse events and CD41 responses to nucleoside analogue therapy for HIV infection. AIDS Clinical Trials Group 175 Team. J Acquir Immune Defic Syndr. 2000; 24: 316–24.
[25] Cherry CL, Affandi JS, Imran D, Yunihastuti E, Smyth K, Vanar S, Kamarulzaman A, Price P. Age and height predict neuropathy risk in patients with HIV prescribed stavudine. Neurology. 2009; 73: 315–320.
[26] Smyth K, Affandi JS, McArthur JC, Bowtell-Harris C, Mijch AM, Watson K, Costello K, Woolley IJ, Price P, Wesselingh SL, Cherry CL. Prevalence of and risk factors for HIV-associated neuropathy in Melbourne, Australia, 1993–2006. HIV Med. 2007; 8: 367–73.
[27] Sacktor N. The epidemiology of human immunodeficiencyvirus–associated neurological disease in the era of highly active antiretroviral therapy Journal of Neuro Virology. 2000; 8 (suppl. 2): 115–121, 200.
[28] Wulff EA, Wang AK, Simpson DM. HIV-associated peripheral neuropathy: epidemiology, pathophysiology and treatment. Drugs. 2000; 59: 1251–1260.
[29] Nakasujja N et al. Human immunodeficiency virus neurological complications: an overview of the Ugandan experience. J Neurovirol. 2005; 11 Suppl 3:26-9.
[30] Menezes MS, Harada KO, Alvarez G. Painful peripheral polyneuropathy after bariatric surgery. Case reports. Rev Bras Anestesiol 2008; 58:252-259.
[31] Ryszard M. Guillain–Barré syndrome. The J Ameri Asso. 2012; 305 (3): 319.
[32] Ministry of Health, Zambia. Adult and adolesecent antiretroviral therapy protocol 2010. 9.
[33] Kalyesubula, R. and Perazella, M. A.2011 Nephrotoxicity of HAART, Academic Editor: Martine Peeters Copyright © 2011.
[34] World Health Organization. Consolidated Guidelines on The use of Antiretroviral Drugs for Treating and Preventing HIV infection Recommendation for Public Health Approach. 2013.
[35] Ford NCA, Mofenson L. Safety of efavirenz in the first trimester of pregnancy: an updated systematic review and metaanalysis. AIDS. 2011; 25, 2301- 2304.
[36] World Health Organization. Technical update on treatment optimization: pharmacological equivalence and clinical interchangeability between lamivudine and emtricitabine, a review of current literature. 2012.
[37] Reynes JTR, Pulido F, Soto-Malave R, Gathe J, Qaqish R, Tian M, Fredrick L, Podsadecki T, Norton M, Nilius A. Lopinavir/Ritonavir Combined with Raltegravir or Tenofovir/Emtricitabine in Antiretroviral-Naive Subjects: 96-Week Results of the PROGRESS Study. AIDS RESEARCH AND HUMAN RETROVIRUSES. 2013; 29, 256- 265.
[38] Saisha J, Mweshi MM, Banda-Chalwe M, Nkhata LA, Kafumukache E, Simpamba M, Mwenda - Ng’uni N. The Prevalence of Guillian-Barre Syndrome and the Rate of Physiotherapy Referral at the University Teaching Hospital, Lusaka, Zambia. International Journal of Neurologic Physical Therapy. 2015; Vol. 2, No. 1, pp. 1-4. doi: 10.11648/j.ijnpt.20160201.11.
[39] Walton T, Vincent M, Richards J, Davidson I. Usefulness of digital gait analysis for assessing patients with gait analysis for assessing patients with Guillain–Barré syndrome. Int J Ther Rehabil 2005; 12: 388–93.
[40] Tuckey J, Greenwood R. Rehabilitation after severe Guillain–Barre syndrome: the use of partial body weight support. Physiother Res Int 2004; 9: 96–103.
[41] Mehrholz J, Pohl M, Kugler J, Burridge J, Mückel S, Elsner B. Physical rehabilitation for critical illness myopathy and neuropathy. Cochrane Database of Systematic Reviews. 2015; Issue 3. Art. No.: CD010942. DOI: 10.1002/14651858.
Cite This Article
  • APA Style

    Margaret M. Mweshi, Richwell Hakacha, Martha Banda-Chalwe, Peter D. C. Phiri, Elliot Kafumukache, et al. (2016). An Evaluation of Common Neuropathies and the Rate of Physiotherapy Referral among Adults on Highly Active Antiretroviral Therapy (HAART) at Maina Soko Military Hospital, Lusaka, Zambia. International Journal of Neurologic Physical Therapy, 2(2), 12-18. https://doi.org/10.11648/j.ijnpt.20160202.11

    Copy | Download

    ACS Style

    Margaret M. Mweshi; Richwell Hakacha; Martha Banda-Chalwe; Peter D. C. Phiri; Elliot Kafumukache, et al. An Evaluation of Common Neuropathies and the Rate of Physiotherapy Referral among Adults on Highly Active Antiretroviral Therapy (HAART) at Maina Soko Military Hospital, Lusaka, Zambia. Int. J. Neurol. Phys. Ther. 2016, 2(2), 12-18. doi: 10.11648/j.ijnpt.20160202.11

    Copy | Download

    AMA Style

    Margaret M. Mweshi, Richwell Hakacha, Martha Banda-Chalwe, Peter D. C. Phiri, Elliot Kafumukache, et al. An Evaluation of Common Neuropathies and the Rate of Physiotherapy Referral among Adults on Highly Active Antiretroviral Therapy (HAART) at Maina Soko Military Hospital, Lusaka, Zambia. Int J Neurol Phys Ther. 2016;2(2):12-18. doi: 10.11648/j.ijnpt.20160202.11

    Copy | Download

  • @article{10.11648/j.ijnpt.20160202.11,
      author = {Margaret M. Mweshi and Richwell Hakacha and Martha Banda-Chalwe and Peter D. C. Phiri and Elliot Kafumukache and Stephanie Nixon},
      title = {An Evaluation of Common Neuropathies and the Rate of Physiotherapy Referral among Adults on Highly Active Antiretroviral Therapy (HAART) at Maina Soko Military Hospital, Lusaka, Zambia},
      journal = {International Journal of Neurologic Physical Therapy},
      volume = {2},
      number = {2},
      pages = {12-18},
      doi = {10.11648/j.ijnpt.20160202.11},
      url = {https://doi.org/10.11648/j.ijnpt.20160202.11},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijnpt.20160202.11},
      abstract = {Background: The advent of highly active antiretroviral therapy (HAART) has changed the prognosis of patients with Human Immunodeficiency Virus (HIV) from invariable death to a manageable chronic condition, with a near-normal life expectancy. However, sensory peripheral neuropathy remains the common complication despite the effective combination of HAART. Little has been reported on the extent of the problem of common neuropathies in adults on HAART in Zambia. Purpose: To determine the prevalence of common neuropathies in adults on HAART and rate of physiotherapy referral among the patients that were seen at the Maina Soko Military Hospital (MSMH). Methods and Results: Data was collected retrospectively from clinical files of patients that were treated on HAART between the years 2011-2013 using a checklist. The statistical package for social sciences (SPSS) version 20 was used for descriptive analysis. A total of 214 clinical files of adults on HAART were identified during the period under review and only 24 cases had some form neuropathies giving a period prevalence of 11.2%. The majority 46% (n=11) age range being 31 to 45 years with more 58% (n=14) females than males 42% (n=10). Almost half 54% (n=13) of the patients were on tenofovir, lamivudine and efavirenz. The most common type of neuropathy 59% (n=14) was polyneuropathy with autonomic neuropathies as co-morbidities and most of these patients 75% (n=18) had not been referred to physiotherapy. Conclusions: Neuropathies are becoming a common problem in patients on HAART given the rising prevalence. Rate of physiotherapy referral among the cases is very low. It is highly recommended that another study on prevalence of neuropathies in adults on HAART be done over a longer period of time to include other hospitals in Zambia. Physiotherapists in Zambia are also challenged to provide evidence on the impact of the interventions given to patients with neuropathies on HAART.},
     year = {2016}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - An Evaluation of Common Neuropathies and the Rate of Physiotherapy Referral among Adults on Highly Active Antiretroviral Therapy (HAART) at Maina Soko Military Hospital, Lusaka, Zambia
    AU  - Margaret M. Mweshi
    AU  - Richwell Hakacha
    AU  - Martha Banda-Chalwe
    AU  - Peter D. C. Phiri
    AU  - Elliot Kafumukache
    AU  - Stephanie Nixon
    Y1  - 2016/04/25
    PY  - 2016
    N1  - https://doi.org/10.11648/j.ijnpt.20160202.11
    DO  - 10.11648/j.ijnpt.20160202.11
    T2  - International Journal of Neurologic Physical Therapy
    JF  - International Journal of Neurologic Physical Therapy
    JO  - International Journal of Neurologic Physical Therapy
    SP  - 12
    EP  - 18
    PB  - Science Publishing Group
    SN  - 2575-1778
    UR  - https://doi.org/10.11648/j.ijnpt.20160202.11
    AB  - Background: The advent of highly active antiretroviral therapy (HAART) has changed the prognosis of patients with Human Immunodeficiency Virus (HIV) from invariable death to a manageable chronic condition, with a near-normal life expectancy. However, sensory peripheral neuropathy remains the common complication despite the effective combination of HAART. Little has been reported on the extent of the problem of common neuropathies in adults on HAART in Zambia. Purpose: To determine the prevalence of common neuropathies in adults on HAART and rate of physiotherapy referral among the patients that were seen at the Maina Soko Military Hospital (MSMH). Methods and Results: Data was collected retrospectively from clinical files of patients that were treated on HAART between the years 2011-2013 using a checklist. The statistical package for social sciences (SPSS) version 20 was used for descriptive analysis. A total of 214 clinical files of adults on HAART were identified during the period under review and only 24 cases had some form neuropathies giving a period prevalence of 11.2%. The majority 46% (n=11) age range being 31 to 45 years with more 58% (n=14) females than males 42% (n=10). Almost half 54% (n=13) of the patients were on tenofovir, lamivudine and efavirenz. The most common type of neuropathy 59% (n=14) was polyneuropathy with autonomic neuropathies as co-morbidities and most of these patients 75% (n=18) had not been referred to physiotherapy. Conclusions: Neuropathies are becoming a common problem in patients on HAART given the rising prevalence. Rate of physiotherapy referral among the cases is very low. It is highly recommended that another study on prevalence of neuropathies in adults on HAART be done over a longer period of time to include other hospitals in Zambia. Physiotherapists in Zambia are also challenged to provide evidence on the impact of the interventions given to patients with neuropathies on HAART.
    VL  - 2
    IS  - 2
    ER  - 

    Copy | Download

Author Information
  • Department of Physiotherapy, School of Medicine, University of Zambia, Lusaka, Zambia

  • Department of Physiotherapy, Maina Soko Military Hospital, Lusaka, Zambia

  • Department of Physiotherapy, School of Medicine, University of Zambia, Lusaka, Zambia

  • Department of Physiotherapy, School of Medicine, University of Zambia, Lusaka, Zambia

  • Department of Anatomy, School of Medicine, University of Zambia, Lusaka, Zambia

  • Department of Physiotherapy, University of Toronto, Toronto, Canada

  • Sections